Nucleophosmin mutations in acute myeloid leukemia: A tale of protein unfolding and mislocalization1. (18th March 2013)

• Record Type: Journal Article
• Authors: Federici, Luca; Falini, Brunangelo
• Is Part Of: Protein science. Volume 22:Number 5(2013:May)
• Page Start: 545
• Page End: 556
• Publication Date: 2013-03-18
• Subjects: Proteins -- Periodicals; 572.6
• DOI: 10.1002/pro.2240
• Languages: English
• ISSNs: 0961-8368

Abstract

<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>Nucleophosmin (NPM1) is an abundant, ubiquitously expressed protein mainly localized at nucleoli but continuously shuttling between nucleus and cytoplasm. NPM1 plays a role in several cellular functions, including ribosome biogenesis and export, centrosome duplication, chromatin remodeling, DNA repair, and response to stress stimuli. Much of the interest in this protein arises from its relevance in human malignancies. NPM1 is frequently overexpressed in solid tumors and is the target of several chromosomal translocations in hematologic neoplasms. Notably, <italic>NPM1</italic> has been characterized as the most frequently mutated gene in acute myeloid leukemia (AML). Mutations alter the C‐terminal DNA‐binding domain of the protein and result in its aberrant nuclear export and stable cytosolic localization. In this review, we focus on the leukemia‐associated NPM1 C‐terminal domain and describe its structure, function, and the effect exerted by leukemic mutations. Finally, we discuss the possibility to target NPM1 for the treatment of cancer and, in particular, of AML patients with mutated <italic>NPM1</italic> gene.</p> </abstract>